1. Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study. Issue 1 (January 2018) Authors: Teply, Benjamin A; Wang, Hao; Luber, Brandon; Sullivan, Rana; Rifkind, Irina; Bruns, Ashley; Spitz, Avery; DeCarli, Morgan; Sinibaldi, Victoria; Pratz, Caroline F; Lu, Changxue; Silberstein, John L; Luo, Jun; Schweizer, Michael T; Drake, Charles G; Carducci, Michael A; Paller, Channing J; Antonar... Journal: Lancet oncology Issue: Volume 19:Issue 1(2018) Page Start: 76 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗